Clinical studies recruiting near Berlin

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Charité Universitätsmedizin Berlin · Pfizer · NCT05020236 A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · Charite-Universitaetsmedizin Berlin - Campus Charite Mitte ( · AbbVie · NCT06602479 Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities
Phase 2 · Charité Campus Virchow Klinikum (CVK) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT06722183 A Study in Healthy Men to Test How Well Different Doses of BI 3821001 Are Tolerated
Phase 1 · CRS Clinical Research Services Berlin GmbH · Boehringer Ingelheim · NCT07526194 Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · Klinische Forschung Berlin Mitte /Pratia Germany · Philip Morris Products S.A. · NCT07108166 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Charite University Medicine Berlin · Joseph Broderick, MD · NCT07227246 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 2760005 · Sanofi · NCT06867094 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Charité Universitaetsmedizin Berlin · Pfizer · NCT07028853 A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Phase 1 · Charite Research Organisation GmbH · Johnson & Johnson Enterprise Innovation Inc. · NCT06116786 MB-CART2019.1 in Refractory Multiple Sclerosis
Phase 1/Phase 2 · Charité Universitätsmedizin Berlin · Miltenyi Biomedicine GmbH · NCT07178431 Personalized Digital Training Intervention to Reduce Inflammation by Correcting Pathological Movement Patterns in Pre-st
NA · Charité - Universitätsmedizin Berlin, BeMoveD - Berlin Movem · Charite University, Berlin, Germany · NCT06596824 A Clinical Study of Arfolitixorin in Patients With mCRC
Phase 1/Phase 2 · Charité - Universitaetsmedizin Berlin · Isofol Medical AB · NCT06922383 Feasibility Study to Evaluate the Safety of the Autologous GrOwnValve Transcatheter Pulmonary Heart Valve
NA · Charité Universitätsmedizin Berlin, Campus Virchow Klinikum, · Charite University, Berlin, Germany · NCT05809856 A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · Charite - Universitatsmedizin Berlin · Takeda · NCT06747351 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Charite Universitaetsmedizin Berlin KöR · Princess Maxima Center for Pediatric Oncology · NCT05327894 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Onkologische Schwerpunktpraxis Kurfuerstendamm ( Site 0600) · Merck Sharp & Dohme LLC · NCT06136559 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Charité - Universitaetsmedizin Berlin - Campus Bejnamin Fran · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Helios Klinikum Berlin-Buch-Klinik für Gynäkologie und Gebur · Merck Sharp & Dohme LLC · NCT06393374 Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06953869 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 6385 · Galderma R&D · NCT06988605 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Charité - Universitätsmedizin Berlin · Pfizer · NCT06758401 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Bristol-Myers Squibb · NCT06929273 LONGitudinal Multi-omics Phenotyping of KIDney Function Alteration
Phase N/A · Experimental and Clinical Research Center · Charite University, Berlin, Germany · NCT05570929 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Central Vermont Medical Center/National Life Cancer Treatmen · NRG Oncology · NCT05624996 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · Helios Klinikum Berlin-Buch · AGO Study Group · NCT05009082 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · Charite Comprehensive Cancer Center · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762 A Non-interventional, Prospective Study With Benralizumab
Phase N/A · Research Site · AstraZeneca · NCT06422078 Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding
Phase N/A · Charité University Medical Center · Xingshun Qi · NCT04662918

Look up another city

Look up another condition